Pre-treatment with calcium prevents endothelial cell activation induced by multiple activators, necrotic trophoblastic debris or IL-6 or preeclamptic sera: Possible relevance to the pathogenesis of preeclampsia

• Published in: Placenta (Eastbourne) 2013-12, Vol.34 (12), p.1196-1201
• Main Authors: Chen, Q, Zhang, Y, Tong, M, Wu, M, Snowise, S, Stone, P, Chamley, L.W
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Calcium - metabolism; Calcium supplementation; Calcium, Dietary - therapeutic use; Cell Communication; Cell Line; Cell-Free System; Dietary Supplements; Embryology: invertebrates and vertebrates. Teratology; Endothelium; Endothelium, Vascular - immunology; Endothelium, Vascular - metabolism; Female; Fundamental and applied biological sciences. Psychology; Humans; Interleukin-6 - blood; Interleukin-6 - genetics; Interleukin-6 - metabolism; Internal Medicine; Necrosis; Nitric oxide; Obstetrics and Gynecology; Osmolar Concentration; Placenta - blood supply; Placenta - immunology; Placenta - metabolism; Placenta - pathology; Placental Circulation; Pre-Eclampsia - immunology; Pre-Eclampsia - metabolism; Pre-Eclampsia - pathology; Pre-Eclampsia - prevention & control; Preeclampsia; Pregnancy; Pregnancy Trimester, First; Recombinant Proteins - metabolism; Time Factors; Tissue Culture Techniques; Trophoblastic debris
• ISSN: 0143-4004; 1532-3102
• DOI: 10.1016/j.placenta.2013.09.014

Abstract Introduction A hallmark of preeclampsia is endothelial cell dysfunction/activation in response to “toxins” from the placenta. Necrotic trophoblastic debris (NTD) is one possible placental toxin and others include inflammatory cytokines. Calcium supplementation appears to protect “at-risk” women from developing preeclampsia by an unknown mechanism. In this study we investigate whether the addition of high levels of calcium to endothelial cells prior to their exposure to the preeclampsia-associated activators could reduce the endothelial cell activation. Methods NTD was harvested from 1st trimester placental explants. Endothelial cells were treated with varied concentrations of calcium prior to exposure to NTD, IL-6 or preeclamptic sera or low levels of calcium. Activation was monitored by quantifying endothelial cell-surface ICAM-1 by ELISA or U937 adhesion to endothelial cells. The activity of endothelial cell nitric oxide synthetase was blocked with L-NAME. Results Pre-treatment with increasing concentrations of calcium inhibited the activation of endothelial cells in response to NTD or IL-6 or preeclamptic sera. Inhibiting nitric oxide synthetase, using L-NAME, reduced the ability of high calcium levels to protect endothelial cell activation. Pre-treatment with calcium did not prevent endothelial cell activation induced by the reduction of the levels of calcium but additional calcium treatment did prevent endothelial cell activation induced by low calcium. Conclusion Our results demonstrate calcium supplementation may prevent the activation of the endothelium in response to activators. These results may partially explain the benefits of calcium supplementation in the reduction of risk for developing preeclampsia and provide in vitro mechanistic support for the use of calcium supplementation in at-risk women.